Vascular Disruptive Agents for the Treatment of Cancer PDF ePub eBook

Books Info:

Vascular Disruptive Agents for the Treatment of Cancer free pdf Angiogenesis (formation of new vessels from pre-existing ones) is a crucial early event in the process of tumor development. New vessels supply the tumor with nutrients that are needed for further local growth and enable distant metastases (Folkman 1995). Judah Folkman (1971) highlighted the potential therapeutic imp- cations of tumor angiogenesis. He hypothesized that if tumor angiogenesis is inhibited, then tumor growth and metastasis will be impaired greatly or even impossible. The subsequent quest for endogenous and exogenous inhibitors of angiogenesis has yielded a variety of promising therapeutic agents that block one or more angiogenic pathways, a few of which have been approved by the FDA (e. g. , bevacizumab, sorafenib, sunitinib) for use as single agents or in combination with chemotherapy in specific populations of cancer patients (Sessa et al. 2008). There has also been a dramatic expansion in the exploration of novel anti-angiogenic agents pre-clinically and in clinical trials (Ferrara 2002). Some of the most promising data comes from the development of agents that inhibit one of the key growth factors involved in tumor angiogenesis - vascular endothelial growth factor (VEGF) (Ferrara et al. 2003). Bevacizumab is a monoclonal antibody against VEGF that was the first an- angiogenic agent that improved significantly the overall survival of patients with colorectal and non-squamous non-small cell lung cancer (Ferrara et al. 2005). Various agents that target tumor angiogenesis are currently under investigation in different cancer types in many clinical trials (Ferrara and Kerbel 2005).

About Tim Meyer

Dr. Tim Meyer is a Senior Lecturer in Medical Oncology at the UCL Cancer Institute in London where he specialises in gastrointestinal cancers and drug development. He trained in medicine at UCL and obtained his PhD from London University, after which he completed specialist training in medical oncology. His major research focus is antibody-based vascular targeting.

Details Book

Author : Tim Meyer
Publisher : Springer-Verlag New York Inc.
Data Published : 20 November 2014
ISBN : 1489982264
EAN : 9781489982261
Format Book : PDF, Epub, DOCx, TXT
Number of Pages : 256 pages
Age + : 15 years
Language : English
Rating :

Reviews Vascular Disruptive Agents for the Treatment of Cancer



17 Comments Add a comment




Related eBooks Download


  • Tumor Angiogenesis and Microcirculation free pdfTumor Angiogenesis and Microcirculation

    Compiling the latest developments in anticancer therapies based on the connection between tumor and capillary growth. "Tumor Angiogenesis and Microcirculation" presents a comprehensive overview of diverse aspects of angiogenesis-related cancer research..


  • Tumor Angiogenesis and Microcirculation free pdfTumor Angiogenesis and Microcirculation

    Compiling the latest developments in anticancer therapies based on the connection between tumor and capillary growth. "Tumor Angiogenesis and Microcirculation" presents a comprehensive overview of diverse aspects of angiogenesis-related cancer research..


  • Tumor Marker  free pdfTumor Marker

    Cancer may be regarded as a group of diseases characterized by an (i) abnormal growth of cells (ii) ability to invade adjacent tissue and even distant organs and(iii) the eventual death of the affected patient if the tumor has progressed beyond that stage when it can be successfully removed ..


  • Imaging Tumor Response to Therapy free pdfImaging Tumor Response to Therapy

    Measurement of solid tumor response to treatment relies mainly on imaging. WHO tumor response criteria and. more recently. RECIST (response evaluation criteria in solid tumors) have provided means to objectively measure tumor response in clinical trials with imaging..


  • Angiogenesis and Cardiovascular Disease free pdfAngiogenesis and Cardiovascular Disease

    Angiogenesis and Cardiovascular Disease provides a comprehensive review of the basic scientific and clinical advances in the field of angiogenesis. and its role in the human cardiovascular system..


  • Vascular Disruptive Agents for the Treatment of Cancer free pdfVascular Disruptive Agents for the Treatment of Cancer

    . Angiogenesis (formation of new vessels from pre-existing ones) is a crucial early event in the process of tumor development. New vessels supply the tumor with nutrients that are needed for further l